Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient Selection for Hypoxia Modifying Treatments Based on Functional Microregional Imaging of Tumor Vasculature, Oxygenation and Proliferation in Squamous Cell Carcinoma of the Larynx

NCT00160095 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT00160095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00160095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient Selection for Hypoxia Modifying Treatments Based on Functional Microregional Imaging of Tumor Vasculature, Oxygenation and Proliferation in Squamous Cell Carcinoma of the Larynx
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Completed
Start date
July 31, 2001
Completion date
March 31, 2013
Enrollment
79 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

larynx cancer